Camlin Fine Sciences Faces Supreme Court Appeal on CGST Order
Camlin Fine Sciences has received a Supreme Court appeal from the CGST office challenging a High Court order. The appeal pertains to an IGST demand of ₹3.33 crore, including interest and penalty, for the period October 2017 to March 2022. The High Court had previously set aside this demand.
The appeal to the Supreme Court, concerning a significant tax demand (₹3.33 crore), can have a material impact on the company's financial standing and ongoing legal expenses, warranting a medium impact assessment.
The company received an appeal against a previous favorable court order, indicating ongoing litigation without a definitive resolution yet. The sentiment is neutral as the outcome is uncertain.
Camlin Fine Sciences Limited has received a copy of an appeal filed by the Office of the Commissioner of CGST & Central Excise, Palghar Commissionerate before the Supreme Court. This appeal is against the High Court's order dated September 11, 2025, which had previously quashed and set aside the demand for IGST amounting to ₹3,33,21,032, along with interest and penalty, for the period from October 23, 2017, to March 31, 2022.
The company had initially informed stakeholders about the High Court's favorable order on January 14, 2025, and September 12, 2025. The receipt of this Supreme Court appeal was communicated to the company on February 3, 2026. This development indicates a continuation of the legal proceedings regarding the tax demand.
What to do with a filing like this
Camlin Fine Sciences Limited filed this with the NSE as a statutory disclosure, categorised under litigation updates. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Camlin Fine Sciences Limited. Read the original for the full detail.